欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2002, Vol. 7 ›› Issue (6): 536-538.

• 研究原著 • 上一篇    下一篇

氯吡格雷在急性冠状动脉闭塞介入治疗中的疗效与安全性评价

孙姗, 吴尚勤, 许静, 陈冬梅, 王惠中   

  1. 天津胸科医院心内科,天津 300051
  • 收稿日期:2002-03-18 修回日期:2002-06-25 出版日期:2002-12-26 发布日期:2020-11-20
  • 通讯作者: 孙姗,女,副主任医师,从事心血管内科临床工作。Tel:022-23147141  E-mail:ss_sas@sohu.com

Application of clopidogrel in percutaneous coronary intervention for acute occlusions of coronary arteries

SUN Shan, WU Shang-Qin, XU Jing, CHEN Dong-Mei, WANG Hui-Zhong   

  1. Department of Cardiology,Tianjin Chest Hospital,Tianjin 300051
  • Received:2002-03-18 Revised:2002-06-25 Online:2002-12-26 Published:2020-11-20

摘要: 目的 观察氯吡格雷在急性冠脉闭塞介入治疗中的疗效和安全性。方法 选择急性冠脉闭塞接受介入治疗的患者92 例,随机分为氯吡格雷组和噻氯匹定组,在常规治疗的基础上各试验药分别给予治疗,对比观察术后3 wk 血小板聚集率及临床情况、不良反应发生率。结果 两组服药后3 wk 血小板聚集率及治疗有效率无统计学差异,氯吡格雷组不良反应及停药率均显著低于噻氯匹定组。结论 氯吡格雷在急性冠脉闭塞介入治疗中的疗效与安全性优于噻氯匹定。

关键词: 氯吡格雷, 噻氯匹定, 急性冠脉闭塞

Abstract: AIM: To observe the effects and safety of clopidogrel used in percutanous coronary intervention(PCI)while acute occlusions of coronary arteries happened.METHODS: 92 patients with acute occlusions of coronary arteries were treated through PCI and they were randomized equally into following groups:clopidogrel group(CPG group)and ticlopidine group(TCpgroup).Each patient was treated with clopidogrel 25 mg bid or ticlopidine 250 mg bid for 4 weeks after PCI.RESULTS: Compared with the control group,there was not significantly difference in platelet aggregation(45.36±2.98 vs 51.60±2.56)and clinical effects(97.95% vs93.02%)after 3 weeks.The proportion of patients with adverse events who had to release the treatment was2.04%(CPG group)and 16.27%(TCpgroup).CONCLUSION: The clinical effect of clopidogrel is similar to ticlopidine and shows less adverse events.

Key words: clopidogrel, ticlopidine, acute occlusions of coronary arteries

中图分类号: